Akademska digitalna zbirka SLovenije - logo
E-resources
Peer reviewed Open access
  • Canadian Cardiovascular Har...
    Tobe, Sheldon W., MD MScCH; Stone, James A., MD PhD; Anderson, Todd, MD; Bacon, Simon, PhD; Cheng, Alice Y.Y., MD; Daskalopoulou, Stella S., MD PhD; Ezekowitz, Justin A., MBBCh MSc; Gregoire, Jean C., MD; Gubitz, Gord, MD; Jain, Rahul, MD MScCH; Keshavjee, Karim, MSc MD; Lindsay, Patty, RN PhD; L’Abbe, Mary, PhD; Lau, David C.W., MD PhD; Leiter, Lawrence A., MD; O’Meara, Eileen, MD; Pearson, Glen J., PharmD; Rabi, Doreen M., MD MSc; Sherifali, Diana, RN PhD; Selby, Peter, MBBS MHSc; Tu, Jack V., MD PhD; Wharton, Sean, MD PharmD; Walker, Kimberly M., MPH; Hua-Stewart, Diane, MPH; Liu, Peter P., MD

    CMAJ. Canadian Medical Association journal, 10/2018, Volume: 190, Issue: 40
    Journal Article

    Tobe et al cite that the Canadian Cardiovascular Harmonized National Guideline Endeavor (C-CHANGE) is a nationally endorsed guideline process, targeting primary care health care practitioners. C-CHANGE promotes patient care by bringing nine guideline groups together, to provide a composite set of recommendations to help clinicians formulate a comprehensive treatment plan directed toward patient priorities. The 2018 update to the C-CHANGE guideline includes a total of 77 recommendations and 52 recommendations that are newly added or updated. A new category for hypertension for high-risk individuals has been developed with a new lower threshold for treatment (130 mm Hg systolic) and target blood pressure (< 120 mm Hg systolic). Multifaceted care for patients with cardiovascular risks includes the cornerstones of health behavior change, such as healthy eating and regular physical activity.